Deutsche Bank raised the firm’s price target on Cigna (CI) to $304 from $301 and keeps a Buy rating on the shares. The firm views the company’s FY26 guidance and FTC deal as possibly a clearing event, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- CVS, ELV, CNC: Health Insurer Stocks Under Pressure as U.S. Expands Fraud Probe
- Subpoenas issued to eight health insurers by House panel, Axios reports
- Cigna price target raised to $375 from $340 at UBS
- Cigna price target raised to $338 from $333 at TD Cowen
- Cigna: Regulatory Overhang Eases, Evernorth Growth Drives Renewed Buy Rating and Earnings Upside